Boston Pharmaceuticals
- Home
- Companies
- Boston Pharmaceuticals
- Products
- Boston - Model BOS161721 - Avizakimab - ...
Boston - Model BOS161721 - Avizakimab -Human Anti-IL-21 Antibody
BOS161721 (avizakimab) is a fully human anti-IL-21 antibody.
Most popular related searches
- IL-21 plays a central role in systemic lupus erythematosus (SLE) through B- and T-cell mediated autoimmunity and generation of autoantibodies to nuclear antigens, a disease hallmark in SLE.
- BOS161721 (avizakimab) demonstrated safety, tolerability, target engagement and pharmacological activity in a Phase 1 study in healthy volunteers (HV).
